Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria

Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application

(2011) Mohammed M Al-Mahrous et al.   Expert Opinion on Drug Discovery

Using an insect model to assess correlation between temperature and virulence in Bacillus weihenstephanensis and Bacillus cereus

(2011) Lotte Stenfors Arnesen et al.   FEMS MICROBIOLOGY LETTERS

Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-ResistantStaphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci

(2011) Ana Maria Rivera et al.   MAYO CLINIC PROCEEDINGS

Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids

(2011) Christoph M. Ernst et al.   MOLECULAR MICROBIOLOGY

TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting Antibiotics

(2010) B. Collins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various  -Lactam Antibiotics

(2010) B. Collins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bacillus cereus, a Volatile Human Pathogen

(2010) E. J. Bottone   CLINICAL MICROBIOLOGY REVIEWS

Cytotoxicity of the Bacillus cereus Nhe Enterotoxin Requires Specific Binding Order of Its Three Exoprotein Components

(2010) T. Lindback et al.   INFECTION AND IMMUNITY

Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria

(2010) James Carroll et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V

(2010) Des Field et al.   Microbial Biotechnology

Listeriosis: a resurgent foodborne infection

(2009) F. Allerberger et al.   CLINICAL MICROBIOLOGY AND INFECTION

Lantibiotics: Mode of Action, Biosynthesis and Bioengineering

(2009) G. Bierbaum et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species

(2009) C. Piper et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis

(2009) Katja Klostermann et al.   JOURNAL OF DAIRY RESEARCH

Genetic Diversity of the Low-Level Vancomycin Resistance Gene vanC-2/vanC-3 and Identification of a Novel vanC Subtype (vanC-4) in Enterococcus casseliflavus

(2009) Shojiro Watanabe et al.   Microbial Drug Resistance

Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system

(2009) Steven Boakes et al.   MOLECULAR MICROBIOLOGY

Mastitis detection: current trends and future perspectives

(2009) Caroline Viguier et al.   TRENDS IN BIOTECHNOLOGY

Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147

(2009) Lucy H. Deegan et al.   Microbial Biotechnology

Determining the Structure and Mode of Action of Microbisporicin, a Potent Lantibiotic Active Against Multiresistant Pathogens

(2008) Franca Castiglione et al.   CHEMISTRY & BIOLOGY

Application of Bacteriocins in the Control of Foodborne Pathogenic and Spoilage Bacteria

(2008) Antonio Gálvez et al.   CRITICAL REVIEWS IN BIOTECHNOLOGY

The generation of nisin variants with enhanced activity against specific Gram-positive pathogens

(2008) Des Field et al.   MOLECULAR MICROBIOLOGY